Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inflammation, a key event in cancer development.

Haitian Lu1, Weiming Ouyang, Chuanshu Huang

  • 1Nelson Institute of Environmental Medicine, New York University School of Medicine, 57 Old Forge Road, Tuxedo, NY 10987, USA.

Molecular Cancer Research : MCR
|April 11, 2006
PubMed
Summary

Nuclear Factor-kappaB (NF-κB) drives inflammation in cancer. Understanding inflammatory microenvironments and signaling molecules is crucial for developing new cancer therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

IRAK4 constrains cellular plasticity during chemically-induced cell fate reprogramming into multiple lineages.

EMBO reports·2026
Same author

KRT14 Drives Basal Muscle-Invasive Bladder Cancer Progression and Lung Metastasis by Directly Binding to and Stabilizing IGF2BP1.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

CYP2A13 upregulation contributes to lung tumorigenesis upon NNK exposure.

Ecotoxicology and environmental safety·2026
Same author

Lnc00892 enhances cisplatin sensitivity by inducing apoptosis through the BTAF1/MDM2/STAT5B/XIAP axis in bladder cancer cells.

Biology direct·2026
Same author

LC3B promotes bladder cancer cell proliferation via the Sp1-cyclin D1/p27 axis with pan-cancer clinical associations.

Cellular signalling·2026
Same author

Correction: The inhibitory effect of compound ChlA-F on human bladder cancer cell invasion can be attributed to its blockage of SOX2 protein.

Cell death and differentiation·2026

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Nuclear Factor-kappaB (NF-κB) is a key regulator of inflammation and cancer development.
  • The tumor microenvironment, comprising inflammatory cells and signaling molecules, is vital for malignant progression.
  • Chronic inflammation can create a mutagenic environment, predisposing to cancer.

Purpose of the Study:

  • To explore the role of NF-κB and the inflammatory microenvironment in cancer.
  • To identify key signaling molecules and inflammatory cells involved in inflammation-associated cancer.
  • To highlight potential therapeutic targets for cancers driven by inflammation.

Main Methods:

  • Review of recent studies on inflammation and cancer.
  • Analysis of signaling pathways involving NF-κB, cytokines, chemokines, STATs, Nrf2, and NFAT.

Related Experiment Videos

  • Examination of the role of inflammatory cells in tumor progression, angiogenesis, invasion, and metastasis.

    • Main Results:

    • NF-κB is a critical mediator linking inflammation and cancer.
    • Inflammatory microenvironments promote tumor growth, angiogenesis, invasion, and metastasis.
    • Cytokines, chemokines, STATs, Nrf2, and NFAT are implicated in inflammation-driven cancer.

    Conclusions:

    • Targeting NF-κB and related inflammatory pathways offers potential for novel cancer therapies.
    • Further research into the specific effects and interactions of these molecules is needed.
    • Elucidating these mechanisms will accelerate the development of effective anti-cancer interventions.